1st Jul 2020 18:15
Benchmark Holdings PLC - Sheffield-based aquaculture genetics and nutrition company - Completes sale of non-core subsidiary FVG Ltd to Pharmaq, part of the global animal health company Zoetis, for a total cash consideration of between GBP14.4 million to GBP14.7 million. Sale comprises Benchmark's veterinary and diagnostic services activities in the UK, Ireland, Norway and Chile. Final consideration will depend on certain final costs to be borne by Benchmark.
Current stock price: 36.10 pence
Year-to-date change: down 18%
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Benchmark Holdings